Intrinsic Value of S&P & Nasdaq Contact Us

Hyperfine, Inc. HYPR NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
59/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.60
+24%

Hyperfine, Inc. (HYPR) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 3 Buy, 1 Hold.

The consensus price target is $1.60, representing an upside of 24% from the current price $1.29.

Analysts estimate Earnings Per Share (EPS) of $-0.56 and revenue of $0.01B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.56 vs est $-0.56 (beat +0%). 2025: actual $-0.43 vs est $-0.46 (beat +5.5%). Analyst accuracy: 97%.

HYPR Stock — 12-Month Price Forecast

$1.60
▲ +24.03% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Hyperfine, Inc., the price target is $1.60.
The average price target represents a +24.03% change from the last price of $1.29.

HYPR Analyst Ratings

Buy
4
Ratings
3 Buy
1 Hold
Based on 4 analysts giving stock ratings to Hyperfine, Inc. in the past 3 months
Rating breakdown
Buy
3 75%
Hold
1 25%
75%
Buy
3 analysts
25%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — HYPR

97%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.56 vs Est –$0.56 ▼ 0.0% off
2025 Actual –$0.43 vs Est –$0.46 ▲ 5.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — HYPR

96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.013B vs Est $0.014B ▼ 7.5% off
2025 Actual $0.014B vs Est $0.013B ▲ 1.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message